论文部分内容阅读
Her-2在乳腺癌、卵巢癌、胃癌、肺腺癌、肾细胞癌中过表达,现已是临床上对乳腺癌和胃癌治疗和预后判断的重要指标之一。因此,准确检测癌组织中Her-2的表达对肿瘤患者的个体化治疗和预后评估至关重要。目前普遍采用免疫组化(IHC)法检测Her-2的表达,其检测过程多为手工方式,无统一的操作流程,往往导致阳性检测结果不一。本文以乳腺癌组织为研究对象,比较不同修复时间对Her-2表达的影
Her-2 is overexpressed in breast cancer, ovarian cancer, gastric cancer, lung adenocarcinoma and renal cell carcinoma and is now one of the most important clinical indicators for the treatment and prognosis of breast cancer and gastric cancer. Therefore, accurate detection of the expression of Her-2 in cancerous tissues is crucial for the individualized treatment and prognostic assessment of cancer patients. At present, immunohistochemistry (IHC) is generally used to detect the expression of Her-2. The detection process is mostly manual, and there is no uniform operation flow, often resulting in different positive test results. In this paper, breast cancer tissue as the object of study, different repair time on Her-2 expression